Allogene Therapeutics Inc (ALLO) — Working Capital to Net Assets Ratio
Allogene Therapeutics Inc (ALLO) has a Working Capital to Net Assets ratio of 72.6% as of September 2025. Working capital of $228.89 Million (current assets of $260.72 Million minus current liabilities of $31.83 Million) is measured against net assets of $315.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ALLO days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Allogene Therapeutics Inc Working Capital to Net Assets (2017–2024)
This chart shows how Allogene Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 72.6%, reflecting working capital of $228.89 Million against net assets of $315.33 Million USD. For the complete balance sheet picture, see how large is Allogene Therapeutics Inc's balance sheet.
Annual Working Capital to Net Assets for Allogene Therapeutics Inc (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Allogene Therapeutics Inc from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check ALLO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 63.4% | $267.86 Million | $422.18 Million | $303.39 Million | $35.52 Million | ▼ -18.9 pp |
| 2023 | 82.4% | $422.04 Million | $512.23 Million | $459.12 Million | $37.08 Million | ▲ +11.2 pp |
| 2022 | 71.2% | $475.10 Million | $666.88 Million | $528.82 Million | $53.73 Million | ▲ +25.5 pp |
| 2021 | 45.8% | $423.42 Million | $925.20 Million | $471.32 Million | $47.91 Million | ▼ -23.8 pp |
| 2020 | 69.5% | $750.81 Million | $1.08 Billion | $845.13 Million | $94.32 Million | ▼ -11.8 pp |
| 2019 | 81.3% | $511.50 Million | $629.02 Million | $544.58 Million | $33.08 Million | ▲ +19.0 pp |
| 2018 | 62.4% | $438.52 Million | $703.16 Million | $467.98 Million | $29.46 Million | ▼ -37.6 pp |
| 2017 | 100.0% | $-2.00K | $-2.00K | $0.00 | $2.00K | — |